NMRD
Nemaura Medical Inc (NMRD)
$2.57--
Key Stats
$2.52
Day's Range
$2.57
$2.15
52-Week Range
$10.73
| Returns | |
| 1 month return | 8.87% |
| 3 month return | 41.06% |
| 1 year return | 70.8% |
| 5 year return | 95.68% |
Company Information
Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT™, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse and prevent the onset of diabetes. Nemaura is planning to submit a PMA application for sugarBEAT® during the second quarter of 2020 for FDA review of this device under medical device regulations. proBEAT™ comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product.
| Organization | Nemaura Medical Inc |
| Employees | 25 |
| CEO | Dewan Chowdhury |
| Industry | Health Technology |
Analyst Recommendation
based on 8 analysts ratings
Buy
87%
Buy
12%
Hold
0%
Sell
Based on 8 Wall street analysts offering stock ratings for Nemaura Medical Inc(by analysts ranked 0 to 5 stars)
Recommendation Trend
Based on 8 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 7 | 7 | 6 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 85.3M |
| Book Value | 0.04 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0 |
| Earnings Share | -0.53 |
| PEG Ratio | 0.0 |
| Wall Street Target Price | 12.17 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Sales (ttm) | 464.66 |
| Price/Book (mrq) | 91.0 |
| Enterprise Value | 93.7M |
| Enterprise Value/Revenue | 510.14 |
| Enterprise Value/Ebitda | 0.0 |
Technicals
| Beta | -0.01 |
| 50 Day MA | 4.08 |
| 200 Day MA | 5.35 |
Institutional Holdings
Tiger Management Llc/ny
1.56%
Vanguard Group Inc
0.54%
Geode Capital Management, LLC
0.45%
Susquehanna International Group, LLP
0.26%
Schmeidler A R & CO Inc
0.26%
State Street Corporation
0.15%
